Impact of salivary flow and lysozyme content and output on the oral health of rheumatoid arthritis patients

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 65, Issue , 2011, Pages 40-45

  Zalewska, Anna ^a   Waszkiewicz, Napoleon ^a   Szajda, Sławomir Dariusz ^a   Waszkiel, Danuta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

DMF (decayed, missing, filled teeth); Lysozyme; Rheumatoid arthritis; Saliva; Salivary flow rate

Indexed keywords

EID: 79958837627     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.932232     Document Type: Article

References (21)

1. Almsthål A., Wikström M.: Oral microflora in subjects with reduced salivary secretion. J. Dent. Res., 1999; 78: 1410-1416.
2. Andonopoulos A.P., Drosos A.A., Skopouli F.N., Acritidis N.C., Moutsopoulos H.M.: Secondary Sjögren's syndrome in rheumatoid arthritis. J. Rheumatol., 1987; 14: 1098-1103.
3. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan S.R., Liang M.H., Luthra H.S.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum., 1987; 31: 315-324.
4. Beighton D., Hellyer P.H., Lynch E.J., Heath M.R.: Salivary levels of mutans streptococci, lactobacilli, yeasts and root caries prevalence in non-institutionalized eldery dental patients. Comm. Dent. Oral Epidemiol., 1991; 19: 302-307.
5. Cassolato S.F., Turnbull R.S.: Xerostomia: clinical aspects and treatment. Gerodontology, 2003; 20: 64-77.
6. Dowd F.J.: Saliva and dental caries. Dent. Clin. North Am., 1999; 43: 579-597.
7. Hammi A.R., Al-Hashimi I.H., Nunn M.E., Zipp M.: Assessment of SS- A and SS- B in parotid saliva of patients with Sjögren's syndrome. J. Oral Pathol. Med., 2005; 34: 198-203. (Pubitemid 40445152)
8. Hansen N.E., Karle H.: Elevated plasma lysozyme in Hodkgkin's disease. An indicator of increased macrophage activity? Scand. J. Haematol., 1979; 22: 173-178. (Pubitemid 9119386)
9. Jankowska A., Waszkiel D., Kobus A., Zwierz K.: Ślina jako główny składnik ekosystemu jamy ustnej. Czȩść II. Mechanizmy odpornościowe. Wiad. Lekarskie, 2007; 5-6: 253-257.
10. Jankowska A., Waszkiel D., Kowalczyk A.: Ślina jako główny składnik ekosystemu jamy ustnej. Czȩść I. Mechanizm wydzielania i funkcje. Wiad. Lekarskie, 2007; 3-4: 148-154.
11. Mancini G., Carbonara A.O., Heremans J.F.: Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry, 1965; 2: 235-254.
12. Mathews S.A., Kurien B.T., Scofield R.H.: Oral manifestations of Sjogren's syndrome. J. Dent. Res., 2008; 87: 308-318.
13. Mignogna M.D., Fedele S., Lo Russo L., Lo Muzio L.: Sialorrhea as early oral clinical manifestation of primary Sjögren's syndrome? Rheumatology, 2003; 42: 1113-1114. (Pubitemid 37221006)
14. Pedersen A.M., Bardow A., Nauntofte B.: Salivary changes and dental caries as a potential oral markers of autoimmune salivary gland dysfunction in primary Sjögren's syndrome. BMC Clin. Pathol., 2005; 5: 4.
15. Pincus T., Callahan L.F.: Taking mortality in rheumatoid arthritis seriously-predictive markers, socioeconomic status and comorbidity. J. Rheumatol., 1986; 13: 841-845. (Pubitemid 17203909)
16. Pollock J.J., Lotardo S., Gwinnett A.J., Mackay B.J., Iacono V.J., Renner R.P.: Antimicrobial interactions of salivary cationic proteins. In: Molecular Basis of Oral Microbial Adhesion, eds.: American Society of Microbiology, Washington D.C. 1985, 136-143.
17. Sreebny L.M., Valdini A.: Xerostomia. Part I: Relationship to other oral symptoms and salivary gland hypofunction. Oral Surg. Oral Med. Oral Pathol., 1988; 66: 451-458.
18. Syrjänen S.M., Syrjänen K.J.: Lysozyme in the labial salivary glands of patients with rheumatoid arthritis. Z. Rheumatol., 1983; 42: 332-336. (Pubitemid 14201012)
19. Torsteinsdòttir I., Hákansson L., Hällgren R., Gudbjörnsson B., Arvidson N.G., Venge P.: Serum lysozyme: a potential marker of monocyte/macrophage activity in rheumatoid arthritis. Rheumatology, 1999; 38: 1249-1254.
20. Venge P.: The monitoring of inflammation by specific cellular markers. Scand. J. Clin. Lab. Invest. Suppl., 1994; 219: 47-54. (Pubitemid 24380369)
21. Zalewska A., Pietruska M.D., Knaś M., Zwierz K.: Niemucynowe białka śliny o wysokim stopniu homologii łańcucha polipeptydowego. Postȩpy Hig. Med. Dośw., 2001; 55: 733-754.